Acasti Pharma Inc. (CVE:ACST) Director Jean-Daniel Bélanger sold 51,199 shares of the stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of C$2.41, for a total value of C$123,389.59.
Shares of Acasti Pharma Inc. (ACST) traded down C$0.03 during trading hours on Monday, hitting C$2.00. The company had a trading volume of 5,031 shares, compared to its average volume of 7,571. Acasti Pharma Inc. has a twelve month low of C$1.47 and a twelve month high of C$2.99.
TRADEMARK VIOLATION WARNING: This report was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/12/11/acasti-pharma-inc-acst-director-sells-c123389-59-in-stock.html.
Acasti Pharma Company Profile
Receive News & Ratings for Acasti Pharma Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma Inc. and related companies with MarketBeat.com's FREE daily email newsletter.